During the course of acute HIV-1 infection, viral replication is generally contained by the development of virus specific immune responses. However, only a minority of infected individuals achieve long term control in the absence of other interventions. These individuals, so called long term nonprogressors, develop, effective anti-HIV-1 immunity characterized by effector CD4 helper cells and cytolytic CD8 T cell responses. In contrast, the majority of chronically infected individuals have a paucity of HIV-1 specific proliferative responses along with dysfunctional CD8+ T cells. The mechanisms by which HIV-1 adversely affects the immune system are unclear but they probably start during the early phases of infection. We speculate that malfunction of the antigen presentation process by dendritic cells, inappropriate hyperactivation of T cells and apoptosis, and/or deletion or unresponsiveness of HIV-1 specific CD4 clones are the responsible factors. This proposal will take advantage of the large numbers of acute and early HIV infections being identified at NYU/Bellevue and affiliated hospitals, to test the hypothesis that antigen presenting cell function, in particular of dendritic cells is seriously compromised during the initial stages of infection.
The specific aims are to: (1) Characterize DC subsets in peripheral blood and mucosal lymphoid tissue of HIV-1 infected individuals during primary infection. DC subsets. Plasmacytoid DCs (pDCs) and CD11c+ myeloid DCs will be enumerated at the time of diagnosis and tracked longitudinally in each subject for up to five years; (2) Assess the function of peripheral blood and mucosal lymphoid DC subsets during primary infection and following initiation of therapy and (3) To establish whether DC precursors, in particular monocyte subsets, are compromised during primary infection. All DC subsets will be evaluated for the presence of HIV-1 infection, their ability to differentiate into mature phenotypes, and their ability to present antigens to T cells. These data should provide important new information regarding the relative numbers of DCs during acute and early infection, whether they are infected with HIV-1 and whether their function is seriously compromised during infection. In particular we will address the possibility that DCs are responsible for the T cell dysfunction that is observed in the CD4 compartment in early infection. DC number and function can be enhanced in vivo by certain modalities, therefore the data obtained from this study may support implementation of approaches to enhance DC activity during acute infection.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
1P01AI057127-01A1
Application #
6808336
Study Section
Acquired Immunodeficiency Syndrome Research Review Committee (AIDS)
Project Start
2004-04-01
Project End
2009-02-28
Budget Start
2004-09-01
Budget End
2005-02-28
Support Year
1
Fiscal Year
2004
Total Cost
$217,288
Indirect Cost
Name
New York University
Department
Type
DUNS #
121911077
City
New York
State
NY
Country
United States
Zip Code
10016
Miller, Elizabeth; Spadaccia, Meredith; Sabado, Rachel et al. (2015) Autologous aldrithiol-2-inactivated HIV-1 combined with polyinosinic-polycytidylic acid-poly-L-lysine carboxymethylcellulose as a vaccine platform for therapeutic dendritic cell immunotherapy. Vaccine 33:388-95
Gornalusse, German G; Mummidi, Srinivas; Gaitan, Alvaro A et al. (2015) Epigenetic mechanisms, T-cell activation, and CCR5 genetics interact to regulate T-cell expression of CCR5, the major HIV-1 coreceptor. Proc Natl Acad Sci U S A 112:E4762-71
Miller, Elizabeth A; Spadaccia, Meredith R; Norton, Thomas et al. (2015) Attenuated Listeria monocytogenes vectors overcome suppressive plasma factors during HIV infection to stimulate myeloid dendritic cells to promote adaptive immunity and reactivation of latent virus. AIDS Res Hum Retroviruses 31:127-36
Miller, Elizabeth; Bhardwaj, Nina (2013) Dendritic cell dysregulation during HIV-1 infection. Immunol Rev 254:170-89
Koblin, Beryl A; Mayer, Kenneth H; Noonan, Elizabeth et al. (2012) Sexual risk behaviors, circumcision status, and preexisting immunity to adenovirus type 5 among men who have sex with men participating in a randomized HIV-1 vaccine efficacy trial: step study. J Acquir Immune Defic Syndr 60:405-13
Miller, Elizabeth A; Spadaccia, Meredith R; O?Brien, Meagan P et al. (2012) Plasma factors during chronic HIV-1 infection impair IL-12 secretion by myeloid dendritic cells via a virus-independent pathway. J Acquir Immune Defic Syndr 61:535-44
Stein, Dylan; Silvera, Richard; Hagerty, Robert et al. (2012) Viewing pornography depicting unprotected anal intercourse: are there implications for HIV prevention among men who have sex with men? Arch Sex Behav 41:411-9
O'Brien, Meagan; Manches, Olivier; Sabado, Rachel Lubong et al. (2011) Spatiotemporal trafficking of HIV in human plasmacytoid dendritic cells defines a persistently IFN-?-producing and partially matured phenotype. J Clin Invest 121:1088-101
Sabado, Rachel Lubong; O'Brien, Meagan; Subedi, Abhignya et al. (2010) Evidence of dysregulation of dendritic cells in primary HIV infection. Blood 116:3839-52
El Hed, Aimee; Khaitan, Alka; Kozhaya, Lina et al. (2010) Susceptibility of human Th17 cells to human immunodeficiency virus and their perturbation during infection. J Infect Dis 201:843-54

Showing the most recent 10 out of 22 publications